Actively Recruiting

Phase Not Applicable
Age: 6Years - 18Years
All Genders
NCT06298188

Risankizumab in Children With Crohn's Disease (RisaKids)

Led by Shaare Zedek Medical Center · Updated on 2024-12-03

90

Participants Needed

1

Research Sites

100 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this observational study is to to prospectively explore the real life short (12 weeks) and longer term (54 weeks) clinical, biochemical and endoscopic outcomes of risankizumab in pediatric CD. This is a 1-year prospective multi-center cohort study of children commencing on risankizumab for pediatric CD with 2 years extension for long-term follow-up. The investigators will record clinical manifestations, blood markers and fecal calprotectin, with monitoring for safety signals including infusion and injection site reactions, pyrexia and infections at various intervals as outlined below. The investigators will also include calprotectin monitoring and fecal sample collection for microbiome and serum samples for drug levels. According to available budget, the investigators will also collect fecal and serum samples for metabolome. Samples collection is optional, thus failure of bio-samples collection will not exclude patients from the study.

CONDITIONS

Official Title

Risankizumab in Children With Crohn's Disease (RisaKids)

Who Can Participate

Age: 6Years - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Children under the age of 18 years
  • Patients diagnosed with Crohn's Disease
  • Patients who have started risankizumab treatment by their physician, either alone or with other Crohn's Disease medications, at any disease stage
Not Eligible

You will not qualify if you...

  • There are no exclusion criteria for this study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Shaare Zedek Medical Center

Jerusalem, Israel

Actively Recruiting

Loading map...

Research Team

N

Nataly Kawazba

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here